Report overview
The macrolide drugs are a group of antibiotics produced by various strains of Streptomyces (spore forming bacteria that grow slowly in soil or water as a branching filamentous mycelium similar to that of fungi) and have a complex chemical (macrocyclic) structure. They act by inhibiting protein synthesis, specifically by blocking the 50S ribosomal subunit. They are broad spectrum antibiotics.
This report contains market size and forecasts of Macrolide Drugs in global, including the following market information:
Global Macrolide Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Macrolide Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Macrolide Drugs companies in 2021 (%)
The global Macrolide Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
14-Membered Ring Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Macrolide Drugs include Abbott Laboratories, Akorn, Eli Lilly & Co., Fresenius Kabi, Gland Pharmm, Sirolimus, Neo Qu?mica, Tacorolimus and Macrolide Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Macrolide Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Macrolide Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Macrolide Drugs Market Segment Percentages, by Type, 2021 (%)
14-Membered Ring Agents
15-Membered Ring Agents
16-Membered Ring Agents
Ketolides
Global Macrolide Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Macrolide Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Hospitalshospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Macrolide Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Macrolide Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Macrolide Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Macrolide Drugs revenues share in global market, 2021 (%)
Key companies Macrolide Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Macrolide Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Akorn
Eli Lilly & Co.
Fresenius Kabi
Gland Pharmm
Sirolimus
Neo Qu?mica
Tacorolimus
Macrolide Pharmaceuticals
Mylan
Pfizer
Sanofi
Merck & Co.
Sandoz International
Teva Pharmaceutical Industries
WOCKHARDT
